Antineoplastic Combined Chemotherapy ProtocolsInflammationInflammation MediatorsChemotherapy, AdjuvantCytokinesTumor Necrosis Factor-alphaInterleukin-8LipopolysaccharidesMacrophagesNF-kappa BInterleukin-6Mice, Inbred C57BLCells, CulturedToll-Like Receptor 4Toll-Like Receptor 2Antineoplastic AgentsCombined Modality TherapyCisplatinSignal TransductionInterleukin-1betaMonocytesMice, KnockoutCyclophosphamideDoxorubicinTreatment OutcomeSeoul virusMyeloid Differentiation Factor 88ChemokinesCell LineInterleukin-1RNA, MessengerGene Expression RegulationImmunity, InnateToll-Like ReceptorsNeoadjuvant TherapyUp-RegulationInterleukin-10LungDisease-Free SurvivalEpithelial CellsMicrogliaBreast NeoplasmsTime FactorsEtoposideDisease Models, AnimalChemokine CCL2Reverse Transcriptase Polymerase Chain ReactionNeutrophilsSurvival AnalysisNeoplasm StagingMacrophage ActivationEnzyme-Linked Immunosorbent AssayPrognosisSurvival RateLung NeoplasmsMice, Inbred BALB CDrug Administration ScheduleInterferon-gammaAnti-Inflammatory AgentsApoptosisDose-Response Relationship, DrugMethotrexateNitric Oxide Synthase Type IIEndothelial CellsHMGB1 ProteinToll-Like Receptor 9p38 Mitogen-Activated Protein KinasesGene ExpressionIntercellular Adhesion Molecule-1Toll-Like Receptor 6Macrophages, PeritonealCarboplatinSepsisAntigens, CD14PaclitaxelI-kappa B ProteinsBlotting, WesternInduction ChemotherapyVinblastineCyclooxygenase 2Flow CytometryCell Line, TumorTranscription Factor RelADendritic CellsNeoplasm Recurrence, LocalTaxoidsChemokine CCL5Burkholderia cenocepaciaMacrophages, AlveolarInterleukin-12Membrane GlycoproteinsDown-RegulationIfosfamideBleomycinLeukocytes, MononuclearNitric OxideNeoplasmsDrug Resistance, NeoplasmCaspase 1Receptors, Immunologic